The U.S. Supreme Court is allowing a new trial in the case of a woman who got breast cancer after taking hormone replacement therapy and is seeking punitive damages against Wyeth Pharmaceuticals.

The justices today rejected Wyeth’s attempt to block the trial because it is to be limited to punitive damages. Wyeth also wanted the high court to throw out $2.75 million compensatory damages that the woman, Donna Scroggin, won after suing Wyeth and Upjohn Co., another drugmaker. Both companies now are owned by Pfizer Inc.